Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
patent blue V, Quantity: 25 mg/mL
Guerbet Australia Pty Ltd
Patent blue V
Injection, solution
Excipient Ingredients: water for injections; sodium chloride; dibasic sodium phosphate dodecahydrate
Subcutaneous
5 X 2mL
Not scheduled. Not considered by committee
Colours the lymph vessels so that they can then be injected with an X-ray contrast medium
Visual Identification: Deep, blue solution; Container Type: Ampoule; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1991-10-21
PATENT BLUE V - Consumer Medicine Information Page 1 of 2 PATENT BLUE V SOLUTION FOR INJECTION _CONSUMER MEDICINE INFORMATION (CMI) _ _ _ WHAT IS IN THIS LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN AN INJECTION OF PATENT BLUE V. It tells you some of the more important points you need to know about this product. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. WHAT IS IN THE INJECTION Patent Blue V is a sterile dye solution for injection. It belongs to the group of triphenylmethane dyes used to reveal vessels in order to improve the visualisation of certain vessels of your body. WHAT PATENT BLUE V IS USED FOR PATENT BLUE V is used by your doctor to prepare a radiological examination or as a direct aid to diagnosis of some diseases. BEFORE RECEIVING IT _ _ _WHEN YOU MUST NOT BE GIVEN _ _IT _ BEFORE YOU RECEIVE AN INJECTION OF PATENT BLUE V, YOU MUST TELL YOUR DOCTOR IF: • you are allergic (hypersensitive) to the active substance ‘patent blue’, to another triphenylmethane dye or any of the other ingredients of Patent Blue V listed at the end of this leaflet • you are pregnant. _BEFORE YOU ARE GIVEN IT _ TELL YOUR DOCTOR IF YOU ARE ALLERGIC TO ANY OTHER MEDICINES OR ANY FOODS, DYES OR PRESERVATIVES. TELL YOUR DOCTOR OR PHARMACIST IF YOU ARE TAKING OR HAVE RECENTLY TAKEN ANY OTHER MEDICINES, INCLUDING MEDICINES OBTAINED WITHOUT A PRESCRIPTION. IN PARTICULAR, PLEASE INFORM YOUR DOCTOR IF YOU ARE TAKING MEDICINES FOR TREATING A HEART CONDITION OR HIGH BLOOD PRESSURE. TELL YOUR DOCTOR IF YOU ARE PREGNANT OR YOU MAY BE PREGNANT. You must never be given Patent Blue V if you are pregnant. TELL YOUR DOCTOR IF YOU ARE BREASTFEEDING OR PLANNING TO BREASTFEED. _TAKING OTHER MEDICINES _ TELL YOUR DOCTOR IF YOU ARE TAKING ANY OTHER MEDICINES, INCLUDING ANY THAT YOU GET WITHOUT A PRESCRIPTION FROM A PHARMACY, SUPERMARKET OR HEALTH FOOD SHOP. Some medicines may interfere with PATENT BLUE V. These include medicines used to treat high blood pressure, such as beta-blo Lugege kogu dokumenti
1(6) AUSTRALIAN PRODUCT INFORMATION PATENT BLUE V SOLUTION FOR INJECTION 1 NAME OF THE MEDICINE Patent Blue V 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Patent Blue V injection solution contains 25 mg/mL (2.5% w/v) of Patent Blue V (sodium salt) as the active ingredient. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Solution for injection. Patent Blue V injection solution is a deep blue sterile, isotonic solution. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Colours the lymph vessels so that they can then be injected with an X-ray contrast medium. 4.2 D OSE AND METHOD OF ADMINISTRATION For subcutaneous use only. 2 mL of Patent Blue V injection solution is diluted with an equal volume of sterile normal saline (an alternative method advocates dilution with 1% lignocaine hydrochloride solution) and 0.5 mL of diluted dye is injected into the subcutaneous tissue of each interdigital web space. When the lower extremities are being examined, 1 mL is also injected below the tip of each malleolus. The lymphatics should then be visible through the skin and it is important that there should be no accidental spillage of the dye. Patent Blue V may be used for children at the surgeon's discretion. After the administration of Patent Blue V, the patient must be monitored for at least 30 minutes. Note. After injection of the dye a bluish coloration of the skin occurs, which normally disappears within 24 to 48 hours. More persistent coloration which should not be confused with cyanosis, may occasionally be seen in cases of lymphatic stasis or circulatory disorder, this persistence may be avoided by using the minimum quantity of dye. An area of blue coloration can persist around the injection site for 8 to 10 days. 2(6) 4.3 C ONTRAINDICATIONS • Hypersensitivity to Patent Blue V, triphenylmethane dyes or any of the excipients listed in section 6.1. • Pregnancy. 4.4 S PECIAL WARNINGS AND PRECAUTIONS FOR USE There is a risk of allergic reactions regardless of the administration r Lugege kogu dokumenti